ALK and anaplastic large cell lymphoma: Two ALK peptides (SLAMLDLLHV, GVLLWEIFSL) located on the ALK kinase domain have already been shown to be immunogenic CD8+T-cell epitopes (HLA-A*0201-restricted) in ALK-positive ALCL patients [34].